Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-19-018081
Filing Date
2019-10-07
Accepted
2019-10-07 19:25:54
Documents
1
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 2669
  Complete submission text file 0001140361-19-018081.txt   3951
Mailing Address 700 PENNSYLVANIA DRIVE EXTON PA 19341
Business Address
Magni Guido (Reporting) CIK: 0001437150 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 191141677

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations